Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 27091 AL 27105

Role of LIMK1-cofilin-actin axis in dendritic spine dynamics in Alzheimer's disease

Paciello F, Battistoni M, Martini S, Simone C, Pastore F, Sollazzo R, Grassi C, Ripoli C.

Cell Death Dis. 2025 Jun 3;16(1):431. doi: 10.1038/s41419-025-07741-7.

Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer's disease

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Saad HM, Al-Gareeb AI, Albuhadily AK.

Inflammopharmacology. 2025 Jun;33(6):2951-2962. doi: 10.1007/s10787-025-01796-w. Epub 2025 Jun 3.

MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodies

Agosta F, Cecchetti G, Spinelli EG, Ghirelli A, Rugarli G, Filippi M.

Curr Opin Neurol. 2025 Aug 1;38(4):289-297. doi: 10.1097/WCO.0000000000001388. Epub 2025 Jun 4.

Bioactive compound nanoparticles for Alzheimer's disease

Kshirsagar N, Patil A, Suryawanshi M.

Inflammopharmacology. 2025 Jun;33(6):2963-2976. doi: 10.1007/s10787-025-01801-2. Epub 2025 Jun 5.

Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments

Pattanaik SK, Anil PM, Jena S, Rath D.

J Ethnopharmacol. 2025 Jul 24;351:120092. doi: 10.1016/j.jep.2025.120092. Epub 2025 Jun 6.

Alzheimer's Disease: A Review of Molecular Mechanisms and Therapeutic Implications by Targeting Sirtuins, Caspases, and GSK-3

Pandya K, Roul K, Tripathi A, Belemkar S, Sinha A, Erol M, Kumar D.

ACS Chem Neurosci. 2025 Jun 18;16(12):2178-2195. doi: 10.1021/acschemneuro.5c00207. Epub 2025 Jun 9.

Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta and Gamma Secretases

Kumar D, Anand P, Singh SK.

Curr Alzheimer Res. 2025;22(5):344-358. doi: 10.2174/0115672050380899250602042028.

The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer

Chalmers JC, Hernandez-Kapila YL.

Periodontol 2000. 2025 Jun;98(1):220-227. doi: 10.1111/prd.12631. Epub 2025 Jun 11.

Tirzepatide: a novel therapeutic approach for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Waheed HJ, Al-Gareeb AI, Faheem SA, Alexiou A, Papadakis M, El-Saber Batiha G.

Metab Brain Dis. 2025 Jun 11;40(5):221. doi: 10.1007/s11011-025-01649-z.

Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer's drug discovery: Promising futuristic structural designs

Dorababu A.

J Pharmacol Exp Ther. 2025 Jul;392(7):103606. doi: 10.1016/j.jpet.2025.103606. Epub 2025 May 14.

Targeting Acetylcholinesterase with Oxytocin: A New Avenue in Alzheimer's Disease Therapeutics

Danta CC, Chaudhari P, Nefzi A.

ACS Chem Neurosci. 2025 Jul 2;16(13):2336-2339. doi: 10.1021/acschemneuro.5c00383. Epub 2025 Jun 17.

What would it take to prove that a chronic infection is a causal agent in Alzheimer's disease?

Brutkiewicz RR, Cao W, Morgan D, Reis RSD, Suryadevara V, Willette AA, Willette SA, Wyatt-Johnson SK, Duggan MR.

Trends Neurosci. 2025 Aug;48(8):608-623. doi: 10.1016/j.tins.2025.05.009. Epub 2025 Jun 16.

Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations

Hossain MS, Hussain MH.

Pharmacol Res Perspect. 2025 Aug;13(4):e70131. doi: 10.1002/prp2.70131.

Autophagy and Alzheimer's Disease: Mechanisms and Impact Beyond the Brain

Hein ZM, Vishnumukkala T, Karikalan B, Alkatiri A, Hussan F, Jagadeesan S, Kamaruzzaman MA, Che Ramli MD, Che Mohd Nassir CMN, Gopalakrishna PK.

Cells. 2025 Jun 16;14(12):911. doi: 10.3390/cells14120911.

Cytoskeletal Proteins and Alzheimer's Disease Pathogenesis: Focusing on the Interplay with Tau Pathology

Jiang G, Xie G, Li X, Xiong J.

Biomolecules. 2025 Jun 6;15(6):831. doi: 10.3390/biom15060831.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias